BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12491928)

  • 1. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
    Stockley TL; Ray PN
    Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
    [No Abstract]   [Full Text] [Related]  

  • 2. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
    Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
    Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
    Navon R; Proia RL
    Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for the common Ashkenazi jewish Tay-Sachs +1 IVS-12 splice-junction mutation: first report.
    Strasberg P; Warren I; Skomorowski MA; Feigenbaum A
    Hum Mutat; 1997; 10(1):82-3. PubMed ID: 9222766
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
    Drucker L; Proia RL; Navon R
    Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as a rapid screening method to detect mutations causing Tay-Sachs disease.
    Srinivasan JR; Liu YH; Venta PJ; Siemieniak D; Killeen AA; Zhu Y; Lubman DM
    Rapid Commun Mass Spectrom; 1997; 11(10):1144-50. PubMed ID: 9218358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation at the invariant acceptor splice site of intron 9 in the HEXA gene [IVS9-1 G-->T] detected by a PCR-based diagnostic test.
    Brown DH; Triggs-Raine BL; McGinniss MJ; Kaback MM
    Hum Mutat; 1995; 5(2):173-4. PubMed ID: 7749415
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
    Navon R; Proia RL
    Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.
    Grebner EE; Tomczak J
    Am J Hum Genet; 1991 Mar; 48(3):604-7. PubMed ID: 1825595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of a pseudodeficiency allele among Tay-Sachs carriers.
    Tomczak J; Boogen C; Grebner EE
    Am J Hum Genet; 1993 Aug; 53(2):537-9. PubMed ID: 8328470
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with Tay-Sachs disease.
    Tanaka A; Fujimaru M; Choeh K; Isshiki G
    J Hum Genet; 1999; 44(2):91-5. PubMed ID: 10083731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR analysis of hair root specimens to detect Tay-Sachs disease carriers in Ashkenazi Jews.
    Brillante R; Yang V; Proos A; Burnett L
    Clin Chem; 1995 Feb; 41(2):321-2. PubMed ID: 7874790
    [No Abstract]   [Full Text] [Related]  

  • 17. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
    Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
    Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study of the molecular epidemiology of Tay-Sachs disease in Europe.
    Akli S; Boue J; Sandhoff K; Kleijer W; Vamos E; Young E; Gatti R; Di Natale P; Motte J; Vanier MT
    Eur J Hum Genet; 1993; 1(3):229-38. PubMed ID: 8044648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
    Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
    Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.